Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder

Treprostinil palmitil (TP), a prodrug of treprostinil, is being developed as an inhalation powder (TPIP) for the treatment of patients with pulmonary arterial hypertension (PAH) and pulmonary hypertension due to interstitial lung disease (PH-ILD). In ongoing human clinical trials, TPIP is administer...

Descripción completa

Detalles Bibliográficos
Autores principales: Gauani, Helena, Baker, Thomas, Li, Zhili, Malinin, Vladimir S., Perkins, Walter R., Sullivan, Eugene J., Cipolla, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057251/
https://www.ncbi.nlm.nih.gov/pubmed/36986795
http://dx.doi.org/10.3390/pharmaceutics15030934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057251/
https://www.ncbi.nlm.nih.gov/pubmed/36986795
http://dx.doi.org/10.3390/pharmaceutics15030934

Ejemplares similares